Hong Kong stocks' innovative drug sector fell in early trading, with BeiGene falling more than 6%

2025-05-07 09:44:48

The Hong Kong stock market's innovative drug sector fell in early trading, with BeiGene falling more than 6%, Rongchang Biopharma falling more than 5%, Innovent Biologics, WuXi Biologics, and Junshi Biosciences all falling.

BeiGene WuXi Biologics

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Air India flight returns after takeoff due to technical issues
                            2025-06-16

                                    Southbound funds made a large net purchase of 5.743 billion yuan today. In terms of Hong Kong Stock Connect (Shanghai), China Construction Bank and Meituan-W received net purchases of HK$1.108 billion and HK$493 million respectively; Xiaomi Group-W ranked first in net sales, with an amount of HK$1.489 billion; in terms of Hong Kong Stock Connect (Shenzhen), Meituan-W and Kangfang Biopharma received net purchases of HK$622 million and HK$206 million respectively; Xiaomi Group-W ranked first in net sales, with an amount of HK$391 million.
                            2025-06-16

                                    Arm (ARM.O): We are better than Nvidia on a wider range of platforms.
                            2025-06-12

                                    Espressif: Wi-Fi 7 and AI computing chips will be launched in the next two to three years
                            2025-06-19

                                    JD.com: Stablecoin is being tested in the Hong Kong Monetary Authority and is expected to be launched in the fourth quarter of this year
                            2025-06-19